Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 618 record(s)

Req # A-2023-000598

All notes made by the Health Canada employees who reviewed the Novavax Nuvaxovid COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2020 to July 31, 2020.

Organization: Health Canada

0 page(s)
February 2024

Req # A-2023-001260

All records mentioning "reverse transcription" since 2023-12-01.

Organization: Health Canada

0 page(s)
February 2024

Req # A-2023-001287

All ADRs from Date January 2022- January 11, 2024 for cosmetic products.

Organization: Health Canada

0 page(s)
February 2024

Req # A-2023-001369

Obtain data from water monitoring conducted on the Fjord or Saguenay rivers for the 2007-2022 period.

Organization: Health Canada

0 page(s)
February 2024

Req # A-2023-001382

Obtain certain information regarding the state of company records held by your organization. Company: Groupe BFL Inc. (NEQ: 1169110567) 2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Technologies Échangeurs Gaz-Air (TEGA) Inc. (NEQ: 1148440044) 2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Innovation Nagas Inc. (also: Nagas Innovation Inc.) (NEQ: 1166256652) 101-2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Bousquet Technologies Inc. (NEQ: 1142014423) 101-2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Bousquet Frères Ltd. (NEQ: 1163420616) 101-2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9.

Organization: Health Canada

0 page(s)
February 2024

Req # A-2023-001385

All communications to/from Health Canada (HC), Public Health Agency Of Canada (PHAC) and National Advisory Committee on Immunization (NACI) or any subcommittee, agency, ad hoc group, project team regarding correspondence from Dr. Theresa (“Tess”) Lawrie or Tess Lawrie about ivermectin in the period of 2020-2023.

Organization: Health Canada

0 page(s)
February 2024

Req # A-2023-000594

All notes made by the Health Canada employees who reviewed the AstraZeneca Vaxzevria COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2020 to July 31, 2020.

Organization: Health Canada

0 page(s)
January 2024

Req # A-2023-000601

All notes made by the Health Canada employees who reviewed the Janssen Jcovden (Johnson & Johnson) COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2020 to July 31, 2020.

Organization: Health Canada

0 page(s)
January 2024

Req # A-2023-001171

Information about whether or not Canada donates or sends blood to foreign countries and if yes to which countries did Canada send blood during the years from 2019 until present time.

Organization: Health Canada

0 page(s)
January 2024

Req # A-2023-001214

Correspondence relating to any abbreviated new drug submission (ANDS) filed since July 1, 2023 where the medicinal ingredient is liraglutide alone and the indication includes chronic weight management.

Organization: Health Canada

0 page(s)
January 2024
Date modified: